Literature DB >> 3829578

Dose-dependent pharmacokinetics of acetaminophen: evidence of glutathione depletion in humans.

J T Slattery, J M Wilson, T F Kalhorn, S D Nelson.   

Abstract

The time course of excretion of acetaminophen and its metabolites in urine was determined in eight healthy adults (seven men and one woman) who ingested 1 gm of the drug and collected timed urine samples for 24 hours. The mean time of peak excretion rate was 1.3 to 3.7 hours for acetaminophen, its glucuronide, sulfate, cysteine, mercapturate, and methoxy metabolites but 13.5 hours for methylthioacetaminophen. The mean half-life of acetaminophen was 3.1 hours and the mean half-life of the metabolites other than methylthioacetaminophen ranged from 4.1 to 5.7 hours. The half-life of methylthiometabolite could not be determined because of its very late peak time. In a second study the effect of dose on the clearance of acetaminophen was determined in nine healthy adult subjects (eight men and one woman) who received doses of 0.5 and 3 gm acetaminophen on separate occasions, separated by 4 to 10 days. The renal clearance of acetaminophen and the formation clearances of the sulfate, glutathione, and catechol metabolites were lower (by 38%, 41%, 35%, and 46%, respectively) at the higher dose. The renal clearance of acetaminophen sulfate and glucuronide conjugates were not different between doses. In a third study (10 men), 10 gm N-acetylcysteine was found to increase the formation clearance of the sulfate conjugate by 27% and that of the glutathione conjugate by 10%. The data suggest that the hepatic supply of reduced glutathione and 3'-phosphoadenosine 5'-phosphosulfate begins to be depleted over the range of 0.5 to 3 gm acetaminophen and that the depletion is overcome by the administration of N-acetylcysteine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3829578     DOI: 10.1038/clpt.1987.50

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  25 in total

Review 1.  Paracetamol: new vistas of an old drug.

Authors:  Alfio Bertolini; Anna Ferrari; Alessandra Ottani; Simona Guerzoni; Raffaella Tacchi; Sheila Leone
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

2.  The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation.

Authors:  Mitchell R McGill; Matthew R Sharpe; C David Williams; Mohammad Taha; Steven C Curry; Hartmut Jaeschke
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

3.  Population pharmacokinetics of intravenous acetaminophen and its metabolites in major surgical patients.

Authors:  Katie H Owens; Philip G M Murphy; Natalie J Medlicott; Julia Kennedy; Mathew Zacharias; Neil Curran; Sree Sreebhavan; Mark Thompson-Fawcett; David M Reith
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-05-21       Impact factor: 2.745

4.  Therapeutic paracetamol treatment in older persons induces dietary and metabolic modifications related to sulfur amino acids.

Authors:  Estelle Pujos-Guillot; Gisèle Pickering; Bernard Lyan; Gilles Ducheix; Marion Brandolini-Bunlon; Françoise Glomot; Dominique Dardevet; Claude Dubray; Isabelle Papet
Journal:  Age (Dordr)       Date:  2011-02-22

5.  Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity.

Authors:  B H Lauterburg; M E Velez
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

6.  Disposition of acetaminophen and indocyanine green in cystic fibrosis-knockout mice.

Authors:  S G Kulkarni; A A Pegram; P C Smith
Journal:  AAPS PharmSci       Date:  2000

Review 7.  Utility of acetylcysteine in treating poisonings and adverse drug reactions.

Authors:  P A Chyka; A Y Butler; B J Holliman; M I Herman
Journal:  Drug Saf       Date:  2000-02       Impact factor: 5.606

Review 8.  Paracetamol poisoning in children and hepatotoxicity.

Authors:  A Penna; N Buchanan
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

9.  Should a lower treatment line be used when treating paracetamol poisoning in patients with chronic alcoholism?: a case for.

Authors:  Nicholas A Buckley; Jayasri Srinivasan
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

10.  Pharmacokinetic consequences and toxicologic implications of metyrapone-induced alterations of acetaminophen elimination in man.

Authors:  R E Galinsky; E B Nelson; D E Rollins
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.